PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
5.02%
Positive revenue growth while 3141.T is negative. John Neff might see a notable competitive edge here.
1.81%
Positive gross profit growth while 3141.T is negative. John Neff would see a clear operational edge over the competitor.
2.13%
Positive EBIT growth while 3141.T is negative. John Neff might see a substantial edge in operational management.
6.86%
Positive operating income growth while 3141.T is negative. John Neff might view this as a competitive edge in operations.
1.99%
Positive net income growth while 3141.T is negative. John Neff might see a big relative performance advantage.
2.00%
Positive EPS growth while 3141.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
2.00%
Positive diluted EPS growth while 3141.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
70.95%
10Y revenue/share CAGR under 50% of 3141.T's 198.07%. Michael Burry would suspect a lasting competitive disadvantage.
66.15%
5Y revenue/share CAGR similar to 3141.T's 62.73%. Walter Schloss might see both companies benefiting from the same mid-term trends.
36.76%
3Y revenue/share CAGR 1.25-1.5x 3141.T's 30.98%. Bruce Berkowitz might see better product or regional expansions than the competitor.
100.00%
10Y OCF/share CAGR in line with 3141.T's 100.00%. Walter Schloss would see both as similarly efficient over the decade.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
212.66%
Net income/share CAGR at 50-75% of 3141.T's 334.33%. Martin Whitman might question if the firm’s product or cost base lags behind.
73.93%
5Y net income/share CAGR above 1.5x 3141.T's 27.17%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
37.10%
3Y net income/share CAGR 50-75% of 3141.T's 50.70%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
219.61%
Equity/share CAGR of 219.61% while 3141.T is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
131.65%
5Y equity/share CAGR above 1.5x 3141.T's 62.06%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
64.76%
3Y equity/share CAGR above 1.5x 3141.T's 37.31%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
77.71%
AR growth well above 3141.T's 7.14%. Michael Burry fears inflated revenue or higher default risk in the near future.
1.23%
Inventory shrinking or stable vs. 3141.T's 11.45%. David Dodd confirms the company’s supply-chain is more efficient if sales are unaffected.
2.13%
Asset growth at 50-75% of 3141.T's 3.56%. Martin Whitman questions if the firm is lagging expansions or if the competitor invests more aggressively.
2.84%
BV/share growth above 1.5x 3141.T's 0.69%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
57.98%
Debt growth far above 3141.T's 15.41%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
0.69%
SG&A declining or stable vs. 3141.T's 2.38%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.